Literature DB >> 27408071

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer.

V Dutta1, G S Chopra2, K Sahai3, S K Nema4.   

Abstract

BACKGROUND: There is a great deal of disparity in the incidence of breast cancer in rural and urban India on one hand and between India and Western population on the other.
METHODS: We analysed steroid receptor status in cases of breast cancer in a small sample of patients in armed forces. Infiltrating duct carcinomas of breast recorded histologically in mastectomy specimens in last two years were accessioned in the present study with reference to patient and tumour characteristics. RESULT: In contrast to the higher rates reported in western literature, only 33 % of the tumours expressed estrogen receptors (ER) and progesterone receptors (PR), of which 24% were ER positive and 30% PR positive. Negative steroid receptor status did not correlate with presence or absence of metastatic nodes, however it was predominant amongst the high grade infiltrating duct carcinomas in this study. Necrosis and lymphovascular invasion demonstrated an inverse relationship with the ER/ PR reactivity. 70% of the node positive cases expressed Her -2/ Neu, reflecting a higher immunoreactivity in this subset of patients. Aneusomy for chromosomes 1, 11 and 17 was common in node positive cases.
CONCLUSION: Evaluation of chromosomal aberrations by Fluorescent In Situ Hybridization (FISH) technique correlates well with traditional histological parameters.

Entities:  

Keywords:  Breast carcinoma; Her –2/ Neu; Hormone receptors

Year:  2011        PMID: 27408071      PMCID: PMC4921764          DOI: 10.1016/S0377-1237(08)80137-2

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  15 in total

1.  HER2 or not HER2: that is the question.

Authors:  Harold J Burstein; Eric P Winer
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

2.  Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes.

Authors:  I Mittra; A A Redkar; R A Badwe
Journal:  J Surg Oncol       Date:  1995-10       Impact factor: 3.454

Review 3.  The Indian scene.

Authors:  R Chopra
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

4.  Morphologic spectrum of estrogen receptor-negative breast carcinoma.

Authors:  Richard Scawn; Sami Shousha
Journal:  Arch Pathol Lab Med       Date:  2002-03       Impact factor: 5.534

5.  Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.

Authors:  D Ichikawa; N Hashimoto; M Hoshima; T Yamaguchi; K Sawai; Y Nakamura; T Takahashi; T Abe; J Inazawa
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

6.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

7.  Hormone receptor status of breast cancer in India: a study of 798 tumours.

Authors:  S B Desai; M T Moonim; A K Gill; R S Punia; K N Naresh; R F Chinoy
Journal:  Breast       Date:  2000-10       Impact factor: 4.380

8.  Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge.

Authors:  Daigo Yamamoto; Hideto Senzaki; Hiroyuki Nakagawa; Homa Okugawa; Hideki Gondo; Kanji Tanaka
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

9.  erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.

Authors:  A D Thor; D A Berry; D R Budman; H B Muss; T Kute; I C Henderson; M Barcos; C Cirrincione; S Edgerton; C Allred; L Norton; E T Liu
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

10.  Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients.

Authors:  Michaela Aubele; Gert Auer; Herbert Braselmann; Jörg Nährig; Horst Zitzelsberger; Leticia Quintanilla-Martinez; Jan Smida; Axel Walch; Heinz Höfler; Martin Werner
Journal:  Anal Cell Pathol       Date:  2002       Impact factor: 2.916

View more
  1 in total

1.  First Comprehensive Report of Clinicopathological Profile of Breast Cancer from Bihar, India.

Authors:  Vivek Rathod; Chandan K Jha; Upasna Sinha; Prashant K Singh; Anil Kumar; Punam P Bhadani; Manoj Kumar
Journal:  Indian J Surg Oncol       Date:  2021-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.